TNGX Tango Therapeutics, Inc.
Tango Therapeutics, Inc. (TNGX) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 30% planned / 70% discretionary
Largest single sale: $4.8M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Crystal Adam 2 fills | President, R&D | Sell 10b5-1 | 27,000 | $27.24 | $735.5K | 137,476 −16.4% of holding | |
| Crystal Adam 2 fills | President, R&D | Sell 10b5-1 | 27,000 | $29.59 | $798.9K | 123,114 −18% of holding | |
| Crystal Adam 2 fills | President, R&D | Sell 10b5-1 | 27,000 | $22.87 | $617.6K | 136,603 −16.5% of holding | |
| Crystal Adam 2 fills | President, R&D | Sell 10b5-1 | 27,000 | $21.23 | $573.1K | 116,843 −18.8% of holding | |
| Crystal Adam | President, R&D | Sell 10b5-1 | 38,460 | $25.00 | $961.5K | 112,622 −25.5% of holding | |
| Crystal Adam | President, R&D | Sell 10b5-1 | 27,000 | $21.20 | $572.5K | 112,622 −19.3% of holding | |
| Crystal Adam | President, R&D | Sell | 12,000 | $20.11 | $241.3K | 112,622 −9.6% of holding | |
| Crystal Adam | President, R&D | Sell 10b5-1 | 20,251 | $15.00 | $303.8K | 112,622 −15.2% of holding | |
| Crystal Adam | President, R&D | Sell 10b5-1 | 54,345 | $12.77 | $694.2K | 132,873 −29% of holding | |
| Weber Barbara 2 fills | Director, Executive Chair | Sell | 30,519 | $12.26 | $374.3K | 1,629,587 −1.8% of holding | |
| Crystal Adam 2 fills | President, R&D | Sell | 18,452 | $12.26 | $226.3K | 187,419 −9% of holding | |
| Beckman Daniella 2 fills | Chief Financial Officer | Sell | 10,317 | $12.26 | $126.5K | 184,410 −5.3% of holding | |
| Sell | 477,401 | $10.15 | $4.8M | 13,386,574 −3.4% of holding | |||
| Sell | 500,000 | $8.02 | $4.0M | 13,863,975 −3.5% of holding | |||
| Sell | 363,541 | $7.04 | $2.6M | 14,363,975 −2.5% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.